UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Y | Z
Number of items: 97.


Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) pp. 1602-1609. 10.1158/1535-7163.MCT-06-0018.

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4(+) T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4+ T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: JOURNAL OF HEPATOLOGY. (pp. S11 - S11). ELSEVIER SCIENCE BV


Bergamaschi, D; Samuels, Y; Sullivan, A; Zvelebil, M; Breyssens, H; Bisso, A; Del Sal, G; (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53. NATURE GENETICS , 38 (10) pp. 1133-1141. 10.1038/ng1879.

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) pp. 642-650. 10.1182/blood.2005-07-3041.

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) 642 - 650. 10.1182/blood.2005-07-3041.

Billottet, C; Grandage, VL; Gale, RE; Quattropani, A; Rommel, C; Vanhaesebroeck, B; Khwaja, A; (2006) A selective inhibitor of the p110 delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. ONCOGENE , 25 (50) 6648 - 6659. 10.1038/sj.onc.1209670.

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: (pp. 9517-).

Bridgewater, JA; Floore, A; Warmoes, MO; Veer Van't, L; (2006) Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary? J Clin Oncol , 24 (18_suppl) 20117-.

Buchmueller, KL; Bailey, SL; Matthews, DA; Taherbhai, ZT; Register, JK; Davis, ZS; Bruce, CD; (2006) Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm. BIOCHEMISTRY-US , 45 (45) 13551 - 13565. 10.1021/bi061245c.

Buffa, FM; Bentzen, SM; Atasoy, BM; Daley, FM; Richman, PI; Dische, S; Wilson, GD; (2006) The response of head and neck tumours to radiotherapy may be influenced by the interaction between cell proliferation and vascularization. In: (Proceedings) 3rd International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology. (pp. S65-S66). ELSEVIER IRELAND LTD

Burcombe, R; Wilson, GW; Dowsett, M; Khan, I; Richman, PI; Daley, F; Detre, S; (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31-. 10.1186/bcr1508.


Carrasco, DR; Fenton, T; Sukhdeo, K; Protopopova, M; Enos, M; You, MJ; Di Vizio, D; (2006) The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell , 9 (5) pp. 379-390. 10.1016/j.ccr.2006.03.028.

Casado, E; Tabernero, J; Melichar, B; Bridgewater, J; Bennouna, J; Delord, J; Sopala, M; (2006) Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial. J Clin Oncol , 24 (18_suppl) 3593-.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) pp. 7411-7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) pp. 1669-1675. 10.1158/1535-7163.MCT-06-0033.

Chong, G; Bhatnagar, A; Cunningham, D; Cosgriff, TM; Harper, PG; Steward, W; Bridgewater, J; (2006) Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol , 17 (3) pp. 437-442. 10.1093/annonc/mdj090.

Cutillas, PR; Khwaja, A; Graupera, M; Pearce, W; Gharbi, S; Waterfield, M; Vanhaesebroeck, B; (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. P NATL ACAD SCI USA , 103 (24) 8959 - 8964. 10.1073/pnas.0602101103. Gold open access


Donovan, E; Coles, C; Westbury, C; Yarnold, J; (2006) Breast. In: External Beam Therapy. Oxford University Press

de Bruin, EC; van de Velde, CJ; van de Pas, S; Nagtegaal, ID; van Krieken, JH; Gosens, MJ; Peltenburg, LT; (2006) Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res , 12 (21) pp. 6432-6436. 10.1158/1078-0432.CCR-06-0231.


Flores, L; Staples, A; Mackay, H; Howard, C; Uthe, P; Sexton, J; Buchmueller, K; (2006) Synthesis and evaluation of LVF-I-141: An intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , 231 ? - ?.

Flores, LV; Staples, AM; Mackay, H; Howard, CM; Uthe, PB; Sexton, JS; Buchmueller, KL; (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. CHEMBIOCHEM , 7 (11) 1722 - 1729. 10.1002/cbic.200600155.

Follows, GA; Dhami, P; Gottgens, B; Bruce, AW; Campbell, PJ; Dillon, SC; Smith, AM; (2006) Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites. GENOME RES , 16 (10) 1310 - 1319. 10.1101/gr.5373606.

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature , 441 (7091) 366 - 370. 10.1038/nature04694.

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; (2006) Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. NATURE , 441 (7091) pp. 366-370. 10.1038/nature04694.

Fox, J; Alabassi, A; Patkar, V; Rose, T; Black, E; (2006) An ontological approach to modelling tasks and goals. COMPUT BIOL MED , 36 (7-8) 837 - 856. 10.1016/j.compbiomed.2005.04.011.

Fox, J; Patkar, V; Thomson, R; (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) pp. 49-54.

Friedmann, BJ; Caplin, M; Savic, B; Shah, T; Lord, CJ; Ashworth, A; Hartley, JA; (2006) Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. MOL CANCER THER , 5 (2) 209 - 218. 10.1158/1535-7163.MCT-05-0239.


Gregory, SG; Barlow, KF; McLay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; (2006) The DNA sequence and biological annotation of human chromosome 1. Nature , 441 (7091) pp. 315-321. 10.1038/nature04727.


Hamaguchi, A.; (2006) Molecular and cellular pharmacology of novel pyrrolo [2,1-c] [1,4] diazepine-based anticancer agents. Doctoral thesis, University of London. Green open access

Ho, E; Vassileva, V; Lim-Soo, P; Allen, C; Piquette-Miller, M; (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: (Proceedings) 107th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics. (pp. P11-P11). MOSBY, INC

Hopper, C.; (2006) Photodynamic therapy for the treatment of oral cancer. Doctoral thesis, University of London. Green open access


Jacobs, IJ; Mackay, J; Menon, U; Skates, SJ; Rosenthal, AN; Fraser, L; (2006) Familial ovarian screening--effective or ineffective? British Journal of Cancer , 23 (9) pp. 1126-1127.

Jenkins, V; Shilling, V; Deutsch, G; Bloomfield, D; Morris, R; Allan, S; Bishop, H; (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer , 94 (6) pp. 828-834. 10.1038/sj.bjc.6603029.

Jones, RL; Swanton, C; Ewer, MS; (2006) Anthracycline cardiotoxicity. Expert Opin Drug Saf , 5 (6) pp. 791-809. 10.1517/14740338.5.6.791.


Kang, S; Denley, A; Vanhaesebroeck, B; Vogt, PK; (2006) Oncogenic transformation induced by the p110 beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 103 (5) pp. 1289-1294. 10.1073/pnas.0510772103.

Khanduri, S; Gerrard, G; Barton, R; Mulvenna, P; Lee, SM; (2006) Clinical trials assessing the optimal management of brain metastases - The state of play. CLINICAL ONCOLOGY , 18 (10) pp. 744-746. 10.1016/j.clon.2006.08.009.

Kluza, J; Mazinghien, R; Irwin, H; Hartley, JA; Bailly, C; (2006) Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. ANTI-CANCER DRUG , 17 (2) 155 - 164.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; Dische, S; (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol , 24 (5) pp. 727-735. 10.1200/JCO.2005.02.7474.


Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. THORAX , 61 (1) 91 - 91. 10.1136/thx.2005.052233.

Lambros, MB; Simpson, PT; Jones, C; Natrajan, R; Westbury, C; Steele, D; Savage, K; (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) pp. 398-408. 10.1038/labinvest.3700390.

Last, K; Maharaj, L; Perry, J; Strauss, S; Fitzgibbon, J; Lister, TA; Joel, S; (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 , Article 5.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. BIOORG MED CHEM LETT , 16 (24) 6161 - 6164. 10.1016/j.bmcl.2006.09.043.

Le Sann, C; Baron, A; Mann, J; van den Berg, H; Gunaratnam, M; Neidle, S; (2006) New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity. Org Biomol Chem , 4 (7) pp. 1305-1312. 10.1039/b600567e.

Leary, A.; (2006) Quality of life in patients receiving platinum based chemotherapy for advanced non-small cell lung cancer. Doctoral thesis, University of London. Green open access

Lipton, L.R.; (2006) Familial colorectal cancer and polyposis genes, pathways and predictions. Doctoral thesis, University of London. Green open access


Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Yu, D; (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev , 32 (8) pp. 594-606. 10.1016/j.ctrv.2006.08.002.

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. BIOORG MED CHEM LETT , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. CLIN CANCER RES , 12 (21) 6509 - 6516. 10.1158/1078-0432.CCR-06-0769.

McGurk, CJ; Cummings, M; Koberle, B; Hartley, JA; Oliver, RT; Masters, JR; (2006) Regulation of DNA repair gene expression in human cancer cell lines. J CELL BIOCHEM , 97 (5) 1121 - 1136. 10.1002/jcb.20711.

McTiernan, A; Driver, D; Michelagnoli, MP; Kilby, AM; Whelan, JS; (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. ANN ONCOL , 17 (8) 1301 - 1305. 10.1093/annonc/mdl108.

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2006) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. PEDIATR BLOOD CANCER , 46 (3) 345 - 350. 10.1002/pbc.20562.

Moore, MJ; Schultes, CM; Cuesta, J; Cuenca, F; Gunaratnam, M; Tanious, FA; Wilson, WD; (2006) Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem , 49 (2) pp. 582-599. 10.1021/jm050555a.

Moorhouse, AD; Santos, AM; Gunaratnam, M; Moore, M; Neidle, S; Moses, JE; (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc , 128 (50) pp. 15972-15973. 10.1021/ja0661919.

Mudie, NY; Swerdlow, AJ; Higgins, CD; Smith, P; Qiao, ZK; Hancock, BW; Hoskin, PJ; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J CLIN ONCOL , 24 (10) 1568 - 1574. 10.1200/JCO.2005.04.2200.

Murugaesu, N; Schmid, P; Dancey, G; Agarwal, R; Holden, L; McNeish, I; Savage, PM; (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol , 24 (30) pp. 4862-4866. 10.1200/JCO.2006.06.2489.


Nicholls, J.; (2006) Investigating protein complexes that are involved in the function and regulation of the human INK4a/ARF locus. Doctoral thesis, University of London. Green open access


O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. SKELETAL RADIOL , 35 (4) 233 - 239. 10.1007/s00256-005-0006-z.

Okkenhaug, K; Patton, DT; Bilancio, A; Garcon, F; Rowan, WC; Vanhaesebroeck, B; (2006) The p110 delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. JOURNAL OF IMMUNOLOGY , 177 (8) pp. 5122-5128.


Palmieri, C; Dhillon, T; Thirlwell, C; Newsom-Davis, T; Young, AM; Nelson, M; Gazzard, BG; (2006) Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV MED , 7 (5) 291 - 293.

Pankhurst, T; Howie, AJ; Adu, D; Wallace, DM; Lipkin, GW; (2006) Incidental neoplasms in renal biopsies. Nephrol Dial Transplant , 21 (1) pp. 64-69. 10.1093/ndt/gfi149.

Patkar, V; Hurt, C; Steele, R; Love, S; Purushotham, A; Williams, M; Thomson, R; (2006) Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer. BRIT J CANCER , 95 (11) 1490 - 1496. 10.1038/sj.bjc.6603470.

Patton, DT; Garden, OA; Pearce, WP; Clough, LE; Monk, CR; Leung, E; Rowan, WC; (2006) Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. JOURNAL OF IMMUNOLOGY , 177 (10) pp. 6598-6602.

Perumal, M; Pillai, RG; Barthel, H; Leyton, J; Latigo, JR; Forster, M; Mitchell, F; (2006) Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. Cancer Res , 66 (17) pp. 8558-8564. 10.1158/0008-5472.CAN-06-0898.

Pors, K; Shnyder, SD; Teesdale-Spittle, PH; Hartley, JA; Zloh, M; Searcey, M; Patterson, LH; (2006) Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: Potential for development of tumor-selective N-oxides. J MED CHEM , 49 (24) 7013 - 7023. 10.1021/jm0608154.

Purnell, B; Lingerfelt, B; Scott, A; Townes, H; Summerville, K; Hudson, S; Kiakos, K; (2006) Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) Analogs of Duocarmycin C2: Synthesis and Biological Evaluation. MEDICINAL CHEMISTRY , 2 (2) pp. 139-146. 10.2174/157340606776056188.

Purnell, B; Sato, A; O'Kelley, A; Price, C; Summerville, K; Hudson, S; O'Hare, C; (2006) DNA interstrand crosslinking agents: Synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD). BIOORG MED CHEM LETT , 16 (21) 5677 - 5681. 10.1016/j.bmcl.2006.08.005.


Ranson, M; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; Halbert, G; (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res , 12 (5) pp. 1577-1584. 10.1158/1078-0432.CCR-05-2198.

Ravn, P; Patel, A; Andre, M; Bicknell, R; Begent, R; Pedley, B; Chester, K; (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

Rebholz, H; Panasyuk, G; Fenton, T; Nemazanyy, I; Valovka, T; Flajolet, M; Ronnstrand, L; (2006) Receptor association and tyrosine phosphorylation of S6 kinases. FEBS J , 273 (9) 2023 - 2036. 10.1111/j.1742-4658.2006.05219.x.

Reis-Filho, JS; Westbury, C; Pierga, JY; (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol , 59 (3) pp. 225-231. 10.1136/jcp.2005.028324.

Rossi, C; Angelucci, A; Costantin, L; Braschi, C; Mazzantini, M; Babbini, F; Fabbri, ME; (2006) Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. EUR J NEUROSCI , 24 (7) 1850 - 1856. 10.1111/j.1460-9568.2006.05059.x.

Ruszniewski, P; Delle Fave, G; Cadiot, G; Komminoth, P; Chung, D; Kos-Kudla, B; Kianmanesh, R; (2006) Well-differentiated gastric tumors/carcinomas. NEUROENDOCRINOLOGY , 84 (3) 158 - 164. 10.1159/000098007.


Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Shah, T; Hochhauser, D; Frow, R; Quaglia, A; Dhillon, AP; Caplin, ME; (2006) Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J NEUROENDOCRINOL , 18 (5) 355 - 360. 10.1111/j.1365-2826.2006.01425.x.

Shanley, S; McReynolds, K; Ardern-Jones, A; Ahern, R; Fernando, I; Yarnold, J; Evans, G; (2006) Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clinical Cancer Research , 12 (23) pp. 7033-7038. 10.1158/1078-0432.CCR-06-1246.

Sieber, OM; Segditsas, S; Knudsen, AL; Zhang, J; Luz, J; Rowan, AJ; Spain, SL; (2006) Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. GUT , 55 (10) 1440 - 1448. 10.1136/gut.2005.087106.

Spender, LC; Lucchesi, W; Bodelon, G; Bilancio, A; Karstegl, CE; Asano, T; Dittrich-Breiholz, O; (2006) Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55 alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. JOURNAL OF GENERAL VIROLOGY , 87 pp. 2859-2867. 10.1099/vir.0.82128-0.

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 533S - 533S). AMER SOC CLINICAL ONCOLOGY

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. J Clin Oncol , 24 (18_suppl) 9555-.

Strauss, SJ; Maharaj, L; Hoare, S; Johnson, PW; Radford, JA; Vinnecombe, S; Millard, L; (2006) Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. J Clin Oncol , 24 (13) pp. 2105-2112. 10.1200/JCO.2005.04.6789.

Swanton, C; Futreal, A; Eisen, T; (2006) Her2-targeted therapies in non-small cell lung cancer. Clin Cancer Res , 12 (14 Pt 2) 4377s-4383s. 10.1158/1078-0432.CCR-06-0115.

Swanton, C; Tomlinson, I; Downward, J; (2006) Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle , 5 (8) pp. 818-823. 10.4161/cc.5.8.2682.

Syed, N; Smith, P; Sullivan, A; Spender, LC; Dyer, M; Karran, L; O'Nions, J; (2006) Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. BLOOD , 107 (1) pp. 250-256. 10.1182/blood-2005-03-1194.


Thirlwell, C.; (2006) Mechanisms of colorectal tumorigenesis associated with Mut-Y (MYH) deficiency and identification of novel predisposition genes in the multiple adenoma phenotype. Doctoral thesis, University of London. Green open access

Thompson, J; Lepikhova, T; Teixido-Travesa, N; Whitehead, MA; Palvimo, JJ; Jänne, OA; (2006) Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. The EMBO Journal , 25 (12) pp. 2757-2767. 10.1038/sj.emboj.7601161.

Thornton, AD; Ravn, P; Winslet, M; Chester, K; (2006) Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. BRIT J SURG , 93 (12) 1456 - 1463. 10.1002/bjs.5624.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. NAT PROTOC , 1 (3) 1213 - 1222. 10.1038/nprot.2006.127.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Production of recombinant protein in Pichia pastoris by fermentation. NAT PROTOC , 1 (2) 1006 - 1021. 10.1038/nprot.2006.126.


Vanhaesebroeck, B; (2006) Charging the batteries to heal wounds through PI3K. NATURE CHEMICAL BIOLOGY , 2 (9) pp. 453-455. 10.1038/nchembio0906-453.

Vukmanovic-Stejic, M; Zhang, Y; Cook, JE; Fletcher, JM; McQuaid, A; Masters, JE; Rustin, MHA; (2006) Human CD4(+)CD25(hi)Foxp3(+) regulatory T cells are derived by rapid turnover of memory populations in vivo. J CLIN INVEST , 116 (9) 2423 - 2433. 10.1172/JCI28941.


Wallace, DL; Berard, M; Soares, MVD; Oldham, J; Cook, JE; Akbar, AN; Tough, DF; (2006) Prolonged exposure of naive CD8(+) T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. IMMUNOLOGY , 119 (2) 243 - 253. 10.1111/j.1365-2567.2006.02429.x.

Wells, G; Martin, CRH; Howard, PW; Sands, ZA; Laughton, CA; Tiberghien, A; Woo, CK; (2006) Design, synthesis, and biophysical and biological evaluation of a series of Pyrrolobenzodiazepine - Poly(N-methylpyrrole) conjugates. J MED CHEM , 49 (18) 5442 - 5461. 10.1021/jm051199z.

Whelan, J; Seddon, B; Perisoglou, M; (2006) Management of osteosarcoma. Curr Treat Options Oncol , 7 (6) pp. 444-455.


Yau, T; Swanton, C; Chua, S; Sue, A; Walsh, G; Rostom, A; Johnston, SR; (2006) Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncol , 45 (2) pp. 196-201. 10.1080/02841860500486630.


Zhao, Y; Thomas, HD; Batey, MA; Cowell, IG; Richardson, CJ; Griffin, RJ; Calvert, AH; (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. CANCER RES , 66 (10) 5354 - 5362. 10.1158/0008-5472.CAN-05-4275.

This list was generated on Sun Feb 26 03:12:16 2017 GMT.